Veeva Systems has been selected by PharmaEssentia USA Corporation to provide its Data Cloud platform in support of the company's launch of a novel therapy for rare, chronic blood cancers. PharmaEssentia, a biopharmaceutical company focused on hematology, will use Veeva Data Cloud to access customer reference data and prescriber-level insights as it commercializes its treatment in the U.S. market. The deal underscores Veeva's continued traction among emerging biopharma companies preparing specialty and rare disease product launches, where accurate healthcare provider data is critical to targeting the right physicians. Financial terms of the agreement were not disclosed.